Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.69 USD
Change Today +0.24 / 5.39%
Volume 288.8K
BIND On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Scott L. Minick MBA

AgeTotal Calculated CompensationThis person is connected to 99 board members in 10 different organizations across 21 different industries.

See Board Relationships
63--
As of Fiscal Year 2014

Background*

Mr. Scott L. Minick, MBA, served as the Chief Executive Officer and President at BIND Therapeutics, Inc until March 2015. Mr. Minick serves as Venture Partner of Arch Venture Partners, L.P. He serves as a Venture Partner at ARCH Venture Fund VI, L.P., ARCH Venture Fund V, L.P. and ARCH Venture Partners L.P. Mr. Minick serves as an Executive Officer of Biomira USA Inc. He has been Chief Executive Officer and President of BIND Biosciences, Inc. since January 2010. He joined ...

Read Full Background

Corporate Headquarters*

325 Vassar Street
Cambridge, Massachusetts 02139

United States

Phone: 617-491-3400
Fax: 617-491-0351

Board Members Memberships*

Director
Director
Chairman
Director
Director
Director
Director
Director
2007-Present
Director
2014-Present
Director

Education*

MBA
Northwestern University
BA
University of California - San Diego
Post-Doctoral Training
Salk Institute for Biological Studies

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIND:US $4.69 USD +0.24

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIND THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.